Ranbaxy

Ranbaxy hires New York ex-mayor Giuliani to resolve issues with US FDA

18 Sep 2008

US FDA bans import of over 30 Ranbaxy generic drugs

17 Sep 2008

The US FDA has banned the import of over 30 generics including antibiotics and cholesterol medicines made by Ranbaxy at two of its plants in India, alleging “serious” manufacturing deficiencies.

Cabinet likely to clear Daiichi-Ranbaxy deal next month

26 Aug 2008

Finance ministry clears Daiichi-Ranbaxy deal among 24 FDI proposals

06 Aug 2008

Daiichi awaits SEBI nod for launching open offer for Ranbaxy

02 Aug 2008

Ranbaxy applies for US FDA approval for Mohali plant; says WHO approves new ARV drug

02 Aug 2008

After amlodipine in Japan, Ranbaxy launches omerprazole

28 Jul 2008

US House representatives probe FDA approval of Ranbaxy drugs

23 Jul 2008

UK Crown court rejects charges against Ranbaxy

23 Jul 2008

MNC rival trying to scuttle Daiichi deal: Ranbaxy

18 Jul 2008

Ranbaxy Laboratories, hit hard by reports of a US probe, today alleged that these are part of a larger game plan by an MNC to scuttle its deal with Japanese drug major Daiichi Sankyo.

FDA under probe as Ranbaxy says Daiichi deal is sealed

17 Jul 2008

Ranbaxy denies allegation of substandard drug sale; gets nod for stake sale

15 Jul 2008

AEGON Religare Life Insurance gets IRDA approval

30 Jun 2008

Tentative nod from USFDA for Ranbaxy's cancer drug valganciclovir

26 Jun 2008

Daiichi to make open offer for Ranbaxy on August 8

16 Jun 2008

Japanese drug maker Daiichi Sankyo, which agreed to acquire Ranbaxy promoter group's 34.8 per cent stake in Ranbaxy Laboratories, will make an open offer for another 20 per cent in the Indian pharma major on August 8.

Ranbaxy gets partial relief in `atorvastatin' case in Australia

28 May 2008

Ranbaxy's Religare completes 97-per cent acquisition of UK broking firm Hichens for £56 million

27 May 2008

Ranbaxy to develop new drugs for Merck & Co

10 May 2008

Ranbaxy Laboratories, the country's largest drug maker is close to striking a deal for collaborating on research for new drug discovery with Merck.

Ranbaxy settles litigation with AstraZeneca; to sell Nexium in US

15 Apr 2008

With the settlemrent of the patent litigation with AstraZeneca, Ranbaxy's US subsidiary  will commence exclusive marketing of a generic version of ulcer drug Nexium in 2014 in the US

Ranbaxy receives Japanese authorisation for product development outside Japan

08 Apr 2008

Ranbaxy introduces world's first biogeneric injectible drug for osteoporosis

03 Apr 2008

Ranbaxy has introduced the world's first injectible drug for the treatment of osteoporosis using an artificial human hormone

Ranbaxy's Religare becomes first Indian brokerage to acquire London firm

26 Mar 2008

Ranbaxy to introduce dental drug Inersan in India, Nepal

18 Mar 2008

SC refuses to stay Gujarat HC order on Ranbaxy's 'Volini' ad

12 Mar 2008

Ranbaxy board approves de-merger of new drug discovery research unit in to Ranbaxy Life Science Research Ltd

19 Feb 2008